Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Professionals · English

Polymyalgia rheumatica and its mimics

Follow a patient from the first episode of shoulder stiffness to a difficult taper. Open the existing cases, compare imaging findings and review the evidence at the point of decision.

In this guide

Start here

Professional Essentials · Open
Find a mimic by presentation

Recognising mimics

Persistent peripheral synovitis, objective weakness or pain confined to one shoulder changes the examination and the choice of investigation. A glucocorticoid response alone does not establish PMR.

Focal shoulder pain and radiographic osteoarthritis

Review the glenohumeral joint space and marginal osteophytes in Case 004. Decide whether the image fits the distribution of pain.

RheumaView Insights · imaging report · English

Read the shoulder report

Knee chondrocalcinosis and the CPPD differential

Case 015 shows advanced osteoarthritis and probable meniscal chondrocalcinosis. Correlate the radiographic findings with the joint examination and, where appropriate, synovial fluid analysis.

RheumaView Insights · imaging report · English

Read the knee report

When to suspect GCA

New transient or persistent visual loss or diplopia in suspected GCA warrants immediate assessment. Strong clinical suspicion calls for immediate treatment while diagnostic testing is arranged.

Urgent visual symptoms · open GCA guide Full emergency quick card · Professional access

Clinical decisions

High Stakes Carousel · 10 PMR modules

Seven formats in each module: odd one out, matching, swipe, sequence, number, trap and a final duel. Explore red flags, assessment, treatment, safety and research.

RheumaPlay · EN / RU / ES / PL · Modules 01–02 are free open demos without registration. Modules 03–10 require Professional access.

Explore the PMR High Stakes Carousel series

The Wager · 10 PMR modules

Practice clinical decisions from the first assessment through relapse, steroid-sparing treatment and new research. Eight questions are drawn from a pool of twelve in each module.

RheumaPlay · EN / RU / ES / PL · Modules 01–02 are free open demos without registration. Modules 03–10 require Professional access.

Explore the PMR Wager series

A Polymyalgia That Did Not Behave

Twelve encounters over thirty months. Reassess the working diagnosis when the course changes.

Clinical simulation · open

Open the longitudinal case

Symptoms that would not settle on 15 mg

Work through six decisions in the Crucible case, including when an incomplete response should prompt consideration of large-vessel GCA.

Crucible · Professional membership, Discovery Pass or access code

Open Crucible case 17

Vasculitis II · Clinical Rounds

Assess threatened vision, vascular imaging and follow-up in GCA, PMR and Takayasu arteritis.

Clinical Rounds · free with registration

Open Clinical Rounds

Treatment and research

November 9 update to the October clinical review

The October BSR guideline recommends starting prednisolone at 12.5–15 mg/day for newly diagnosed PMR, increasing to 25 mg/day if needed for symptom control. In a small randomized trial of recently diagnosed PMR, methotrexate 25 mg/week increased glucocorticoid-free remission at week 52 from 46% with placebo to 80% with methotrexate. The analysis included 58 participants. BSR guideline · Methotrexate trial

New international imaging recommendations reserve vascular imaging for clinical suspicion of GCA. Evidence is insufficient to support systematic screening for subclinical vasculitis in otherwise asymptomatic patients with PMR. PMR imaging recommendations

In October 2026, the European Commission approved secukinumab for adults with PMR who have an inadequate response to glucocorticoids or relapse during taper. In the United States, secukinumab is approved for adults with PMR when corticosteroids have not worked well enough or when the patient cannot tolerate a corticosteroid taper. EU prescribing information · US prescribing information

The second year of prednisone

Use the clinical review for relapse, steroid-sparing treatment and monitoring when CRP is suppressed. Read current prescribing information for regional indications.

Clinical review · Professional membership, Discovery Pass or access code

Open the clinical review

How JAK/STAT signalling works

See how a cytokine signal reaches the nucleus. The animation explains the molecular target. For PMR-specific outcomes, read BACHELOR and the JADORE-BARI study record.

RheumaView Insights · 3 min 26 s · English audio

Watch on RheumaView Insights

BACHELOR trial

JADORE-BARI trial registration

Bone remodelling and vertebral fragility

The film illustrates bone resorption and formation and how a vertebra can fracture. For glucocorticoid-associated fracture risk, use the ACR guideline alongside the film.

RheumaView Insights · 1 min 54 s · English audio

Open the original film

ACR guideline on glucocorticoid-induced osteoporosis

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Polymyalgia rheumatica